Our achievements in research projects made in close collaboration with our partners are published in peer reviewed journals.
News &
Strategic Partnership of EVOMEDIS GmbH, Medical University and COREMED Graz
Investing in the future of burn medicine: Alliance develops new cell-based therapy in Graz to Foster Wound Healing Innovations
Read More
European Commission grants orphan drug designation for EVOCellic
Important milestone: EVOMEDIS has received Orphan Drug Designation from the European Medicines Agency (EMA) for its novel cell therapy drug for the treatment of severe burns.
Read More
Join our open clinical network and profit from our devolpment expertise.